CETIRIZINE vs TACROLIMUS

Compare CETIRIZINE (Cetirizine Hydrochloride) and TACROLIMUS (Tacrolimus) — clinical data, side effects, and patient experiences.

CETIRIZINE

Cetirizine Hydrochloride, Zyrtec · Other

How it works

Other agent

Approved for

INDICATIONS AND USAGE Perennial Allergic Rhinitis: Cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites

animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing

rhinorrhea

postnasal discharge

OralTablet

TACROLIMUS

Tacrolimus · Immunosuppressant

How it works

12.1 Mechanism of Action Tacrolimus binds to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin (a ubiquitous mammalian intrac...

Approved for

1 INDICATIONS AND USAGE Tacrolimus capsules are calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver

kidney or heart transplants and pediatric patients receiving allogeneic liver transplants in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney

Liver or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection

in adult patients receiving allogeneic kidney transplant [ see Clinical Studies (14.1) ]

OralTablet

Quick Comparison

CETIRIZINETACROLIMUS

Drug Class

Other

Immunosuppressant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CETIRIZINE

Drug Not Working

>10%

Fatigue

1-10%

Rash

1-10%

Headache

1-10%

Itching

1-10%

Nausea

1-10%

Shortness of Breath

1-10%

Hair Loss

1-10%

TACROLIMUS

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

FDA Warnings

CETIRIZINE

No specific warnings

TACROLIMUS

5 WARNINGS AND PRECAUTIONS Not Interchangeable with Extended Release Tacrolimus Products-Medication Errors : Instruct patients or caregivers to recognize the appearance of tacrolimus capsules
5 ) Neurotoxicity: Including risk of Posterior Reversible Encephalopathy Syndrome (PRES), monitor for neurologic abnormalities; reduce or discontinue tacrolimus
9 ) Not recommended for use with sirolimus: Not recommended in liver and heart transplant due to increased risk of serious adverse reactions
1 Lymphoma and Other Malignancies Patients receiving immunosuppressants, including tacrolimus, are at increased risk of developing lymphomas and other malignancies, particularly of the skin

Clinical Trial Data

No head-to-head clinical studies found for CETIRIZINE vs TACROLIMUS.

CETIRIZINE vs TACROLIMUS: What You Should Know

Key Differences

CETIRIZINE is a Other, while TACROLIMUS belongs to the Immunosuppressant class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

TACROLIMUS carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

EVEROLIMUS vs TACROLIMUS→SIROLIMUS vs TACROLIMUS→CYCLOSPORINE OPHTHALMIC SOLUTION vs TACROLIMUS→CYCLOSPORINE vs TACROLIMUS→MYCOPHENILIC ACID vs TACROLIMUS→AZATHIOPRINE vs TACROLIMUS→

Loading comparison data...

CETIRIZINE vs TACROLIMUS

Compare CETIRIZINE (Cetirizine Hydrochloride) and TACROLIMUS (Tacrolimus) — clinical data, side effects, and patient experiences.

CETIRIZINE

Cetirizine Hydrochloride, Zyrtec · Other

How it works

Other agent

Approved for

INDICATIONS AND USAGE Perennial Allergic Rhinitis: Cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites

animal dander and molds in children 6 to 23 months of age. Symptoms treated effectively include sneezing

rhinorrhea

postnasal discharge

OralTablet

TACROLIMUS

Tacrolimus · Immunosuppressant

How it works

12.1 Mechanism of Action Tacrolimus binds to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin (a ubiquitous mammalian intrac...

Approved for

1 INDICATIONS AND USAGE Tacrolimus capsules are calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver

kidney or heart transplants and pediatric patients receiving allogeneic liver transplants in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney

Liver or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection

in adult patients receiving allogeneic kidney transplant [ see Clinical Studies (14.1) ]

OralTablet

Quick Comparison

CETIRIZINETACROLIMUS

Drug Class

Other

Immunosuppressant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

CETIRIZINE

Drug Not Working

>10%

Fatigue

1-10%

Rash

1-10%

Headache

1-10%

Itching

1-10%

Nausea

1-10%

Shortness of Breath

1-10%

Hair Loss

1-10%

TACROLIMUS

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

FDA Warnings

CETIRIZINE

No specific warnings

TACROLIMUS

5 WARNINGS AND PRECAUTIONS Not Interchangeable with Extended Release Tacrolimus Products-Medication Errors : Instruct patients or caregivers to recognize the appearance of tacrolimus capsules
5 ) Neurotoxicity: Including risk of Posterior Reversible Encephalopathy Syndrome (PRES), monitor for neurologic abnormalities; reduce or discontinue tacrolimus
9 ) Not recommended for use with sirolimus: Not recommended in liver and heart transplant due to increased risk of serious adverse reactions
1 Lymphoma and Other Malignancies Patients receiving immunosuppressants, including tacrolimus, are at increased risk of developing lymphomas and other malignancies, particularly of the skin

Clinical Trial Data

No head-to-head clinical studies found for CETIRIZINE vs TACROLIMUS.

CETIRIZINE vs TACROLIMUS: What You Should Know

Key Differences

Safety Considerations

TACROLIMUS carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.